2-Amino-1-(5-bromopyridin-2-yl)-4-(2,4-dichlorophenyl)-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile

Catalog No. :
ACGRVC641
CAS No. :
311774-21-7
Molecular Formula :
C23H19BrCl2N4O
Molecular Weight :
518.24

IUPAC Name:2-amino-1-(5-bromopyridin-2-yl)-4-(2,4-dichlorophenyl)-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile

2-Amino-1-(5-bromopyridin-2-yl)-4-(2,4-dichlorophenyl)-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-1-(5-bromopyridin-2-yl)-4-(2,4-dichlorophenyl)-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile
IUPAC Name2-amino-1-(5-bromopyridin-2-yl)-4-(2,4-dichlorophenyl)-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile
Molecular FormulaC23H19BrCl2N4O
Molecular Weight518.24
SMILESN#CC1=C(N)N(C2=NC=C(Br)C=C2)C3=C(C(CC(C)(C)C3)=O)C1C4=CC=C(Cl)C=C4Cl
InChI KeyNYQYWBYEYCOSEO-UHFFFAOYSA-N
Synonym2-amino-1-(5-bromo-2-pyridinyl)-4-(2,4-dichlorophenyl)-7,7-dimethyl-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarbonitrile;3-Quinolinecarbonitrile, 2-amino-1-(5-bromo-2-pyridinyl)-4-(2,4-dichlorophenyl)-1,4,5,6,7,8-hexahydro-7,7-dimethyl-5-oxo-
CAS No.311774-21-7

Synthetic Route by SureRoute

1. ACGRVC641 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCKWO017 route compound structure diagram
    ACCKWO017624-28-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGRVC641 route product structure diagram
    ACGRVC641311774-21-7
Inquiry

2. ACGRVC641 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGRVC641 route product structure diagram
    ACGRVC641311774-21-7
Inquiry

Comments (0)